Effect of SGLT2 inhibitors on anemia and their possible clinical implications Aleix Cases; Secundino Cigarrán; José Luis Górriz; Julio Nuñez;

Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action Salvador Benlloch; Francesc Moncho; Jose Luis Górriz;

Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist Aleix Cases;